234 related articles for article (PubMed ID: 27338783)
1. Microparticles as biomarkers of venous thromboembolic events.
Campello E; Spiezia L; Radu CM; Simioni P
Biomark Med; 2016 Jul; 10(7):743-55. PubMed ID: 27338783
[TBL] [Abstract][Full Text] [Related]
2. Annexin V
Chen Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Cao X; Zhang W; Liu L; Wu J
Clin Chim Acta; 2022 Nov; 536():169-179. PubMed ID: 36191610
[TBL] [Abstract][Full Text] [Related]
3. Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism.
Fricke A; Ullrich PV; Cimniak AFV; Becherer C; Follo M; Heinz J; Scholber J; Herget GW; Hauschild O; Wittel UA; Stark GB; Bannasch H; Braig D; Eisenhardt SU
BMC Cancer; 2017 Aug; 17(1):527. PubMed ID: 28784104
[TBL] [Abstract][Full Text] [Related]
4. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients.
Thaler J; Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):127-31. PubMed ID: 21792463
[TBL] [Abstract][Full Text] [Related]
6. Microparticles reveal cell activation during IVF - a possible early marker of a prothrombotic state during the first trimester.
Olausson N; Mobarrez F; Wallen H; Westerlund E; Hovatta O; Henriksson P
Thromb Haemost; 2016 Aug; 116(3):517-23. PubMed ID: 27412479
[TBL] [Abstract][Full Text] [Related]
7. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Wang M; Huang X; Zhu M; Zhang S; Zhang Y
Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
[TBL] [Abstract][Full Text] [Related]
8. Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: a role for circulating microparticles?
Campello E; Radu CM; Spiezia L; Simioni P
Clin Chem Lab Med; 2017 Jun; 55(7):934-943. PubMed ID: 27816948
[TBL] [Abstract][Full Text] [Related]
9. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
10. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
[TBL] [Abstract][Full Text] [Related]
11. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
12. Increased circulating microparticles in streptozotocin-induced diabetes propagate inflammation contributing to microvascular dysfunction.
Feng Q; Stork CJ; Xu S; Yuan D; Xia X; LaPenna KB; Guo G; Sun H; Xu LC; Siedlecki CA; Brundage KM; Sheaffer N; Schell TD; He P
J Physiol; 2019 Feb; 597(3):781-798. PubMed ID: 30548258
[TBL] [Abstract][Full Text] [Related]
13. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
Date K; Ettelaie C; Maraveyas A
J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
[TBL] [Abstract][Full Text] [Related]
15. Circulating microparticles and risk of venous thromboembolism.
Bucciarelli P; Martinelli I; Artoni A; Passamonti SM; Previtali E; Merati G; Tripodi A; Mannucci PM
Thromb Res; 2012 May; 129(5):591-7. PubMed ID: 21908018
[TBL] [Abstract][Full Text] [Related]
16. Circulating procoagulant microparticles in cancer patients.
Thaler J; Ay C; Weinstabl H; Dunkler D; Simanek R; Vormittag R; Freyssinet JM; Zielinski C; Pabinger I
Ann Hematol; 2011 Apr; 90(4):447-53. PubMed ID: 20981426
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.
Zwicker JI; Liebman HA; Neuberg D; Lacroix R; Bauer KA; Furie BC; Furie B
Clin Cancer Res; 2009 Nov; 15(22):6830-40. PubMed ID: 19861441
[TBL] [Abstract][Full Text] [Related]
18. Microparticle analysis in disorders of hemostasis and thrombosis.
Mooberry MJ; Key NS
Cytometry A; 2016 Feb; 89(2):111-22. PubMed ID: 25704723
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis.
Zwicker JI
Thromb Res; 2010 Apr; 125 Suppl 2():S89-91. PubMed ID: 20434015
[TBL] [Abstract][Full Text] [Related]
20. An overview of the role of microparticles/microvesicles in blood components: Are they clinically beneficial or harmful?
Burnouf T; Chou ML; Goubran H; Cognasse F; Garraud O; Seghatchian J
Transfus Apher Sci; 2015 Oct; 53(2):137-45. PubMed ID: 26596959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
